Patent · US Active

Methods for lung cancer detection

US12146195B2 · kind B2 · utility

0Cited by

171References

12Claims

0Family size

Assignee

Natera, Inc. · US

Inventors

Bernhard Zimmermann · Manteca, US
Tudor Pompiliu Constantin · Berkeley, US
Raheleh SALARI · San Carlos, US
Huseyin Eser Kirkizlar · Los Angeles, US
Robert Charles Swanton · London, GB
Mariam Jamal-Hanjani · London, GB
Christopher Abbosh · Boughton Monchelsea, GB
Gareth Wilson · Bromley, GB

Key dates

Filing date	Apr 17, 2017
Grant date	Nov 19, 2024
Priority date	—
Expiry date	Apr 17, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/156
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention provides methods for detecting single nucleotide variants in lung cancer, especially stage 3a lung adenocarcinoma and lung squamous cell carcinoma. Additional methods and compositions, such as reaction mixtures and solid supports comprising clonal populations of nucleic acids, are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.